Cue Biopharma is an innovative immunotherapy company dedicated to developing a novel, proprietary class of biologics engineered to selectively modulate the human immune system to treat a broad range of cancers and autoimmune disorders. Cue Biopharma’s Immuno-STAT Biologics are designed to engage directly with and modulate the activity of disease-associated T cells in the patient’s body, potentially offering significant therapeutic advantages while minimizing or eliminating unwanted side effects.

Biotechnology

Cue Biopharma

Cue Biopharma's headquarters in Cambridge, MA, United States

Dan Passeri

Anish Suri

Steven Quayle

Colin Sandercock

Siddhartha Shrivastava

Matteo Levisetti

Kerri-Ann Millar

Hidde Ploegh

Pamela D. Garzone

Karolina Palucka

Aaron Fletcher

Frank Morich

Peter Kiener

Abul K. Abbas

Michael Kalos

Fred Driscoll

Ronald D. Seidel III

Steven Almo

Patrick Verheyen

Rafi Ahmed

The Research and Development Team at Cue Biopharma is focused on advancing the company's immunotherapy therapies by conducting cutting-edge research on biologics designed to modulate the immune system. This team, composed of scientists and leaders across pharmacology, translational medicine, and toxicology, collaborates to design, test, and refine novel therapies that target disease-associated T cells, ultimately aiming to bring innovative treatment solutions for cancers and autoimmune disorders from the lab to clinical application.

Research and Development Team

The Legal and Regulatory Affairs team at Cue Biopharma is responsible for ensuring compliance with applicable laws and regulations governing the development and commercialization of innovative immunotherapies. This team navigates intricate regulatory landscapes, manages legal contracts, and supports clinical operations by providing guidance on regulatory submissions and intellectual property matters, thereby facilitating the advancement of Cue Biopharma's pioneering biologics safely and effectively.

Legal and Regulatory Affairs

The Advisory Team at Cue Biopharma provides strategic guidance and expert insights to enhance the company’s innovative immunotherapy development efforts. Comprising seasoned advisors with extensive experience in biopharmaceuticals and immunology, the team collaborates on scientific and clinical strategies, ensuring the alignment of research initiatives with industry best practices and regulatory requirements. Their collective expertise helps to optimize the efficacy of Cue Biopharma's Immuno-STAT Biologics while navigating the complexities of drug development and commercialization.

Advisory Team

The Finance and Operations team at Cue Biopharma is responsible for managing the company's financial health and operational efficiency. This team oversees budgeting, forecasting, and financial reporting while ensuring optimal resource allocation to support innovative biopharmaceutical development. Additionally, they coordinate supply chain and technical operations, facilitating the seamless integration of financial strategies with operational goals to drive the advancement of novel immunotherapies.

Finance and Operations

The Leadership Team at Cue Biopharma is responsible for setting the strategic vision and direction of the company, guiding the development of innovative immunotherapy solutions. Comprising experts in science, finance, and legal affairs, this team collaborates to ensure the effective execution of projects, oversees regulatory compliance, and drives financial growth, all while advancing the mission to enhance patient care through targeted immuno-modulation therapies.

Cue Biopharma

Org chart

Board & advisors

Teams

Research and Development Team

Legal and Regulatory Affairs

Advisory Team

Finance and Operations

Leadership Team

Offices

Cue Biopharma

Org chart

Board & advisors

Teams

Research and Development Team

Legal and Regulatory Affairs

Advisory Team

Finance and Operations

Leadership Team

Offices

Related companies